Clinical outcomes and the role of bronchoscopic intervention in patients with primary pulmonary salivary gland-type tumors
Primary pulmonary salivary gland-type tumors (PSGTs) are rare tumors that account for less than 1.0% of all lung cancers [1 –3]. According to the World Health Organization criteria classification of lung tumors, salivary gland-type tumors are divided into the following types: adenoid cystic carcinoma (ACC), mucoepidermoid carcinoma (MEC), epithelial-myoepithelial carcinoma (EMC), and pleomorphic adenoma [4]. The most c ommon subtypes include ACC and MEC, which comprise>90% of PSGTs [2]. The EMC and pleomorphic adenomas are extremely rare and have only been sporadically documented [5].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Bo-Guen Kim, Kyungjong Lee, Sang-Won Um, Joungho Han, Jong Ho Cho, Jhingook Kim, Hojoong Kim, Byeong-Ho Jeong Source Type: research
More News: Adenoids | Bronchoscopy | Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | International Medicine & Public Health | Lung Cancer | WHO